PATH Stock - UiPath Inc.
Unlock GoAI Insights for PATH
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.43B | $1.31B | $1.06B | $892.25M | $607.64M |
| Gross Profit | $1.18B | $1.11B | $878.53M | $723.38M | $541.79M |
| Gross Margin | 82.7% | 85.0% | 83.0% | 81.1% | 89.2% |
| Operating Income | $-162,569,000 | $-164,720,000 | $-348,283,000 | $-500,946,000 | $-110,323,000 |
| Net Income | $-73,694,000 | $-89,883,000 | $-328,352,000 | $-525,586,000 | $-92,393,000 |
| Net Margin | -5.2% | -6.9% | -31.0% | -58.9% | -15.2% |
| EPS | $-0.13 | $-0.16 | $-0.60 | $-0.97 | $-0.18 |
UiPath Inc. provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform combines artificial intelligence with desktop recording, back-end mining of both human activity and system logs, and intuitive visualization tools, which enables users to discover, analyze, and identify processes to automate in a centralized portal; offers low-code development environments that allows users in an organization to create attended and unattended automations without any prior knowledge of coding; deploys robots in highly immersive attended experiences or in standalone, unattended modes behind the scenes, and can leverage native connectors built for commonly used line-of-business applications; offers centralized tools designed to manage, test, and deploy automations and ML models across the enterprise; allows customers to manage long running processes that orchestrate work between robots and humans; and enable users to track, measure, and forecast the performance of automation in their enterprise and help businesses ensure compliance with business standards. In addition, the company provides maintenance and support for its software, as well as professional services, such as training and implementation services to facilitate the adoption of its platform. It serves banking, healthcare, financial services, and government entities. UiPath Inc. was founded in 2005 and is headquartered in New York, New York.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| October 2nd 2025 | BMO Capital Markets | Reiterated | Market Perform | $13← $12.5 |
| September 5th 2025 | BMO Capital Markets | Reiterated | Market Perform | $12.5← $15.5 |
| September 5th 2025 | DA Davidson | Resumed | Neutral | $12 |
| March 13th 2025 | BofA Securities | Downgrade | Underperform | $10 |
| December 12th 2024 | UBS | Initiation | Sell | - |
| June 3rd 2024 | Macquarie | Downgrade | Neutral | $12← $29 |
| May 30th 2024 | Needham | Downgrade | Hold | - |
| May 30th 2024 | KeyBanc Capital Markets | Downgrade | Sector Weight | - |
| May 30th 2024 | TD Cowen | Downgrade | Hold | $17← $28 |
| May 30th 2024 | William Blair | Downgrade | Market Perform | - |
| May 30th 2024 | Truist | Downgrade | Hold | $14← $32 |
| May 30th 2024 | BofA Securities | Downgrade | Neutral | $16← $30 |
| April 8th 2024 | KeyBanc Capital Markets | Resumed | Overweight | $27 |
| March 14th 2024 | Needham | Reiterated | Buy | $30← $25 |
| March 14th 2024 | JP Morgan | Upgrade | Overweight | $28← $22 |
Earnings History & Surprises
PATHEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 27, 2026 | — | — | — | — |
Q1 2026 | Mar 11, 2026 | $0.25 | — | — | — |
Q4 2025 | Dec 3, 2025 | $0.15 | $0.16 | +8.7% | ✓ BEAT |
Q3 2025 | Sep 4, 2025 | $0.08 | $0.15 | +87.5% | ✓ BEAT |
Q2 2025 | May 29, 2025 | $0.10 | $0.11 | +7.7% | ✓ BEAT |
Q1 2025 | Mar 12, 2025 | $0.19 | $0.26 | +36.8% | ✓ BEAT |
Q4 2024 | Dec 5, 2024 | $0.07 | $0.11 | +57.1% | ✓ BEAT |
Q3 2024 | Sep 5, 2024 | $0.03 | $0.04 | +22.1% | ✓ BEAT |
Q2 2024 | May 29, 2024 | $0.12 | $0.13 | +11.8% | ✓ BEAT |
Q1 2024 | Mar 13, 2024 | $0.15 | $0.22 | +46.7% | ✓ BEAT |
Q4 2023 | Nov 30, 2023 | $0.07 | $0.12 | +71.4% | ✓ BEAT |
Q3 2023 | Sep 6, 2023 | $0.03 | $0.09 | +161.9% | ✓ BEAT |
Q2 2023 | May 24, 2023 | $0.02 | $0.11 | +384.2% | ✓ BEAT |
Q1 2023 | Mar 15, 2023 | $0.07 | $0.15 | +114.3% | ✓ BEAT |
Q4 2022 | Dec 1, 2022 | $0.01 | $0.05 | +277.6% | ✓ BEAT |
Q3 2022 | Sep 6, 2022 | $-0.11 | $-0.02 | +81.8% | ✓ BEAT |
Q2 2022 | Jun 1, 2022 | $-0.05 | $-0.03 | +40.0% | ✓ BEAT |
Q1 2022 | Mar 30, 2022 | $0.03 | $0.05 | +86.5% | ✓ BEAT |
Q4 2021 | Dec 8, 2021 | $-0.12 | $-0.23 | -100.0% | ✗ MISS |
Q3 2021 | Sep 7, 2021 | $-0.06 | $0.01 | +116.7% | ✓ BEAT |
Latest News
RBC Capital Maintains Sector Perform on UiPath, Raises Price Target to $19
➖ NeutralMorgan Stanley Maintains Equal-Weight on UiPath, Raises Price Target to $19
📈 PositiveDA Davidson Maintains Neutral on UiPath, Raises Price Target to $15
➖ NeutralBarclays Maintains Equal-Weight on UiPath, Raises Price Target to $16
➖ NeutralBMO Capital Maintains Market Perform on UiPath, Raises Price Target to $17
➖ NeutralRBC Capital Maintains Sector Perform on UiPath, Raises Price Target to $16
📈 PositiveEvercore ISI Group Maintains In-Line on UiPath, Raises Price Target to $17
📈 PositiveCanaccord Genuity Maintains Buy on UiPath, Raises Price Target to $19
📈 PositiveMizuho Maintains Neutral on UiPath, Raises Price Target to $15
➖ NeutralWells Fargo Maintains Equal-Weight on UiPath, Raises Price Target to $14
➖ NeutralUiPath shares are trading higher after the company reported better-than-expected Q3 financial results and issued Q4 sales guidance with its midpoint above estimates.
📈 PositiveNeedham Reiterates Hold on UiPathto Hold
➖ NeutralMarket-Moving News for December 4th
➖ NeutralUiPath shares are trading higher after the company reported better-than-expected Q3 financial results and issued Q4 sales guidance with its midpoint above estimates.
📈 PositiveUiPath surges as Q3 results, guidance top expectations
📈 PositiveUiPath Non-GAAP EPS of $0.16 beats by $0.01, revenue of $411.11M beats by $18.24M
📈 PositiveUiPath Sees Q4 Sales $462.000M-$467.000M vs $462.909M Est
➖ NeutralUiPath Q3 Adj. EPS $0.16 Beats $0.15 Estimate, Sales $411.113M Beat $392.967M Estimate
📈 PositiveUiPath Elevates R Systems International To Diamond Partner And Recognizes It As Agentic Automation Fast Track Partner
📈 PositiveDriving ROI With Azure AI Foundry And UiPath: Intelligent Agents In Real-World Healthcare Workflows
📈 PositiveFrequently Asked Questions about PATH
What is PATH's current stock price?
What is the analyst price target for PATH?
What sector is UiPath Inc. in?
What is PATH's market cap?
Does PATH pay dividends?
Similar Stocks
Technology SectorExplore stocks similar to PATH for comparison